Neuropeptides in Newborn Blood May Help Objectively Measure Pain in Babies Who Can't Speak
Substance P, neurokinin A, neuropeptide Y, and cortisol levels in newborn blood correlated with pain scale scores, suggesting peptide biomarkers could help objectively measure neonatal pain.
Quick Facts
What This Study Found
Significant decreases in neuropeptide Y (p = 0.02) and neurokinin A (p = 0.03) were observed.
Key Numbers
How They Did This
The study involved 54 full-term neonates and measured biomarker levels alongside two pain assessment scales.
Why This Research Matters
Understanding neonatal pain is crucial for improving care in newborns. Identifying reliable biomarkers can lead to better pain management strategies.
The Bigger Picture
Pain assessment in newborns is one of the most challenging problems in pediatric medicine. Current tools rely on behavioral observations — facial expressions, crying, body movement — which are subjective and can miss pain in sedated or neurologically impaired infants. Peptide biomarkers like substance P and neuropeptide Y offer the possibility of objective, measurable pain indicators. This connects to the broader field of neuropeptide research showing how the brain's pain signaling molecules can be detected in blood.
What This Study Doesn't Tell Us
The study's sample size was limited to 54 neonates, which may affect the generalizability of the findings.
Questions This Raises
- ?Could a combined peptide biomarker panel plus pain scale score provide more accurate pain assessment than either approach alone?
- ?Why do male newborns show stronger biomarker-pain correlations, and does this reflect biological sex differences in pain processing?
- ?Would these peptide biomarkers be useful in premature infants or those receiving sedation, where behavioral pain scales are less reliable?
Trust & Context
- Key Stat:
- p = 0.02 for NPY change Neuropeptide Y levels significantly decreased in response to painful procedures in full-term newborns
- Evidence Grade:
- This is a prospective observational study with a modest sample of 54 neonates. While the correlations are statistically significant, the small sample size limits generalizability. The prospective design strengthens the findings compared to retrospective approaches.
- Study Age:
- Published in 2023, this study represents current research into peptide biomarkers for neonatal pain. The field is still early-stage, and larger validation studies are needed before clinical implementation.
- Original Title:
- The Role of Substance P, Neurokinin A, Neuropeptide Y, and Cortisol in Assessing Neonatal Pain.
- Published In:
- Neonatal network : NN, 42(2), 65-71 (2023)
- Authors:
- Dionysakopoulou, Christina, Lianou, Loukia, Boutopoulou, Barbara, Giannakopoulou, Margarita, Vlachioti, Efrosini, Koumpagioti, Despoina, Bozas, Evangelos, Matziou, Vasiliki
- Database ID:
- RPEP-06842
Evidence Hierarchy
Frequently Asked Questions
Why is measuring pain in newborns so difficult?
Babies can't verbally report pain, so doctors rely on behavioral signs like crying, facial grimacing, and body movements. These are subjective and can be influenced by many factors. Sedated, premature, or neurologically impaired infants may show few behavioral signs even when experiencing significant pain.
What do substance P and neuropeptide Y have to do with pain?
Substance P is a neuropeptide that transmits pain signals in the nervous system — it's one of the main chemical messengers that tell your brain something hurts. Neuropeptide Y is involved in stress response and pain modulation. Changes in their blood levels reflect what's happening in the pain signaling system.
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-06842APA
Dionysakopoulou, Christina; Lianou, Loukia; Boutopoulou, Barbara; Giannakopoulou, Margarita; Vlachioti, Efrosini; Koumpagioti, Despoina; Bozas, Evangelos; Matziou, Vasiliki. (2023). The Role of Substance P, Neurokinin A, Neuropeptide Y, and Cortisol in Assessing Neonatal Pain.. Neonatal network : NN, 42(2), 65-71. https://doi.org/10.1891/NN.2022-0006
MLA
Dionysakopoulou, Christina, et al. "The Role of Substance P, Neurokinin A, Neuropeptide Y, and Cortisol in Assessing Neonatal Pain.." Neonatal network : NN, 2023. https://doi.org/10.1891/NN.2022-0006
RethinkPeptides
RethinkPeptides Research Database. "The Role of Substance P, Neurokinin A, Neuropeptide Y, and C..." RPEP-06842. Retrieved from https://rethinkpeptides.com/research/dionysakopoulou-2023-the-role-of-substance
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.